Exploring Frequencies of Circulating Specific Th17 Cells against Myeloperoxidase and Proteinase 3 in ANCA Associated Vasculitis

Exploring Frequencies of Circulating Specific Th17 Cells against Myeloperoxidase and Proteinase 3 in ANCA Associated Vasculitis

<b>: </b>Background: The role of the T helper 17 (Th17) cell subset in anti-neutrophil cytoplasm antibodies (ANCA) associated vasculitis (AAV) is controversial. We hypothesized that a specific Th17 response to myeloperoxidase (MPO) or proteinase 3 (PR3) is detectable in AAV patients and...

Full description

Bibliographic Details
Main Authors:	Laura Martinez Valenzuela, Juliana Draibe, Maria Quero, Xavier Fulladosa, Josep Maria Cruzado, Oriol Bestard, Juan Torras
Format:	Article
Language:	English
Published:	MDPI AG 2019-11-01
Series:	International Journal of Molecular Sciences
Subjects:	anca vasculitis th17 il-17 immunology lymphocyte biomarker
Online Access:	https://www.mdpi.com/1422-0067/20/23/5820

Similar Items

Systematic Histological Scoring Reveals More Prominent Interstitial Inflammation in Myeloperoxidase-ANCA Compared to Proteinase 3-ANCA Glomerulonephritis
by: Samy Hakroush, et al.
Published: (2021-03-01)

The Co-inhibitor BTLA Is Functional in ANCA-Associated Vasculitis and Suppresses Th17 Cells
by: Kai Werner, et al.
Published: (2019-12-01)

ANCA-Associated Vasculitis: An Update
by: Salem Almaani, et al.
Published: (2021-04-01)

Methimazole-Induced ANCA Vasculitis: A Case Report
by: Precil Diego Miranda de Menezes Neves, et al.
Published: (2021-08-01)

ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review
by: Rui Wu, et al.
Published: (2021-03-01)

Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis
by: Gwen E. Thompson, et al.
Published: (2020-09-01)

The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study
by: José Agapito Fonseca, et al.
Published: (2021-05-01)

The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study
by: José Agapito Fonseca, et al.
Published: (2021-05-01)

ANCA-associated vasculitis in a 14 years-old patient: a clinical case
by: A. V. Burlutskaya, et al.
Published: (2020-10-01)

Rituximab, Cyclophosphamide, and Corticosteroids for ANCA Vasculitis: The Good, the Bad, and the Ugly
by: Roberta Fenoglio, et al.
Published: (2020-10-01)

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
by: Frank B. Cortazar, et al.
Published: (2018-03-01)

Propylthiouracil-induced ANCA-negative cutaneous small vessel vasculitis
by: Aliaksandr Trusau, et al.
Published: (2018-01-01)

Blue toe syndrome as the initial manifestation of ANCA-associated vasculitis
by: Marinchev Liubomir, et al.
Published: (2013-10-01)

A Case of Crescentic Glomerulonephritis Complicated with Hypocomplementemic Urticarial Vasculitis Syndrome and ANCA-Associated Vasculitis
by: Marenao Tanaka, et al.
Published: (2017-11-01)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
by: Zachary S. Wallace, et al.
Published: (2019-12-01)

ANCA-associated vasculitis in childhood: recent advances
by: Marta Calatroni, et al.
Published: (2017-05-01)

Myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis with a unique imaging presentation of organizing pneumonia: A case report
by: Kazufumi Takada, MD, et al.
Published: (2020-01-01)

The frequency of ANCA-associated vasculitis in a national database of hospitalized patients in China
by: Jiannan Li, et al.
Published: (2018-10-01)

Rituximab Induction and Maintenance in ANCA-Associated Vasculitis: State of the Art and Future Perspectives
by: Elena Treppo, et al.
Published: (2021-08-01)

Low Density Granulocytes in ANCA Vasculitis Are Heterogenous and Hypo-Responsive to Anti-Myeloperoxidase Antibodies
by: Aisling Ui Mhaonaigh, et al.
Published: (2019-11-01)

Nasal microbiome research in ANCA-associated vasculitis: Strengths, limitations, and future directions
by: Andreas Kronbichler, et al.
Published: (2021-01-01)

Reporte de un caso: Vasculitis asociada a ANCA P en el adulto mayor
by: Osvaldo Cardozo
Published: (2020-05-01)

Association of TERT and DSP variants with microscopic polyangiitis and myeloperoxidase-ANCA positive vasculitis in a Japanese population: a genetic association study
by: Aya Kawasaki, et al.
Published: (2020-10-01)

Pathogenesis and Diagnosis of Otitis Media with ANCA-Associated Vasculitis
by: Naohiro Yoshida, et al.
Published: (2014-01-01)

Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study
by: Dimitrios Chanouzas, et al.
Published: (2019-02-01)

Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation
by: Yusuke Miyazaki, et al.
Published: (2020-06-01)

Recommendations of the Brazilian Society of Rheumatology for the induction therapy of ANCA-associated vasculitis
by: Alexandre Wagner Silva de Souza, et al.

ANCA vasculitis in a patient with Alport syndrome: a difficult diagnosis but a treatable disease!
by: Valentine Gillion, et al.
Published: (2017-03-01)

Benzylthiouracil-induced ANCA-associated Vasculitis: A Case Report and Literature Review
by: Fatima Bensiradj, et al.
Published: (2019-12-01)

The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis
by: Sayo Takeda, et al.
Published: (2019-06-01)

MPO-ANCA associated vasculitis with mononeuritis multiplex following influenza vaccination
by: Stefanie Eindhoven, et al.
Published: (2017-12-01)

Fatal pulmonary complication during induction therapy in a patient with ANCA-associated vasculitis
by: Brigita Jonaitytė, et al.
Published: (2016-07-01)

Ten-year experience with rituximab for induction and maintenance therapy in patients with ANCA-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2020-03-01)

Randomized clinical trials in ANCA-associated vasculitis: a systematic analysis of the WHO - International Clinical Trials Registry Platform
by: Michele Iudici, et al.
Published: (2020-05-01)

Pathogenesis and pathology of anti-neutrophil cytoplasmic antibody（ANCA）-associated vasculitis
by: Daisuke Tsukui, et al.
Published: (2021-01-01)

Aortic aneurysm as a complication of myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis
by: Satomura Atsushi, et al.
Published: (2017-12-01)

Chemokine/Cytokine Levels Correlate with Organ Involvement in PR3-ANCA-Associated Vasculitis
by: Janina Müller-Deile, et al.
Published: (2021-06-01)

Persistent hematuria in patients with antineutrophil cytoplasmic antibody-associated vasculitis during clinical remission: chronic glomerular lesion or low-grade active renal vasculitis?
by: Li Lv, et al.
Published: (2017-12-01)

Comprehensive Analysis of Sex Differences at Disease Manifestation in ANCA-Associated Glomerulonephritis
by: Désirée Tampe, et al.
Published: (2021-09-01)

Covid-19 in a patient with ANCA-associated systemic vasculitis, receiving anti-B cell therapy (rituximab)
by: T. V. Beketova, et al.
Published: (2020-09-01)